BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20596915)

  • 1. The role of Smad signaling in vascular and hematopoietic development revealed by studies using genetic mouse models.
    Lan Y; Yang X
    Sci China Life Sci; 2010 Apr; 53(4):485-9. PubMed ID: 20596915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta signaling in vascular biology and dysfunction.
    Goumans MJ; Liu Z; ten Dijke P
    Cell Res; 2009 Jan; 19(1):116-27. PubMed ID: 19114994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Santander C; Brandan E
    Exp Cell Res; 2010 Sep; 316(15):2487-503. PubMed ID: 20471380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Smad signaling in hematopoiesis.
    Larsson J; Karlsson S
    Oncogene; 2005 Aug; 24(37):5676-92. PubMed ID: 16123801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
    Goumans MJ; Mummery C
    Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
    Yu Z; Xing Y
    Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling.
    Söderberg SS; Karlsson G; Karlsson S
    Ann N Y Acad Sci; 2009 Sep; 1176():55-69. PubMed ID: 19796233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
    Mazerbourg S; Hsueh AJ
    Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
    Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
    Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
    Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
    Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Signaling pathways of transforming growth factor beta family members].
    Zimowska M
    Postepy Biochem; 2006; 52(4):360-6. PubMed ID: 17536504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.
    Larsson J; Goumans MJ; Sjöstrand LJ; van Rooijen MA; Ward D; Levéen P; Xu X; ten Dijke P; Mummery CL; Karlsson S
    EMBO J; 2001 Apr; 20(7):1663-73. PubMed ID: 11285230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tgf-beta signaling alterations and colon cancer.
    Bellam N; Pasche B
    Cancer Treat Res; 2010; 155():85-103. PubMed ID: 20517689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.